Hepatoblastoma Cancer Stem Cells Express PD-L1, Reveal Plasticity and Can Emerge upon Chemotherapy

The biology of cancer stem cells (CSCs) of pediatric cancers, such as hepatoblastoma, is sparsely explored. This is mainly due to the very immature nature of these tumors, which complicates the distinction of CSCs from the other tumor cells. Previously, we identified a CSC population in hepatoblasto...

Full description

Bibliographic Details
Main Authors: Mieun Lee-Theilen, Delaine D. Fadini, Julia R. Hadhoud, Fleur van Dongen, Gabriela Kroll, Udo Rolle, Henning C. Fiegel
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/23/5825
_version_ 1797463548941565952
author Mieun Lee-Theilen
Delaine D. Fadini
Julia R. Hadhoud
Fleur van Dongen
Gabriela Kroll
Udo Rolle
Henning C. Fiegel
author_facet Mieun Lee-Theilen
Delaine D. Fadini
Julia R. Hadhoud
Fleur van Dongen
Gabriela Kroll
Udo Rolle
Henning C. Fiegel
author_sort Mieun Lee-Theilen
collection DOAJ
description The biology of cancer stem cells (CSCs) of pediatric cancers, such as hepatoblastoma, is sparsely explored. This is mainly due to the very immature nature of these tumors, which complicates the distinction of CSCs from the other tumor cells. Previously, we identified a CSC population in hepatoblastoma cell lines expressing the CSC markers CD34 and CD90, cell surface Vimentin (csVimentin) and binding of OV-6. In this study, we detected the co-expression of the immune escape factor PD-L1 in the CSC population, whereas the other tumor cells remained negative. FACS data revealed that non-CSCs give rise to CSCs, reflecting plasticity of CSCs and non-CSCs in hepatoblastoma as seen in other tumors. When we treated cells with cisplatin and decitabine, a new CD34<sup>+/low</sup>OV-6<sup>low</sup>CD90<sup>+</sup> population emerged that lacked csVimentin and PD-L1 expression. Expression analyses showed that this new CSC subset shared similar pluripotency and EMT features with the already-known CSCs. FACS results further revealed that this subset is also generated from non-CSCs. In conclusion, we showed that hepatoblastoma CSCs express PD-L1 and that the biology of hepatoblastoma CSCs is of a plastic nature. Chemotherapeutic treatment leads to another CSC subset, which is highly chemoresistant and could be responsible for a poor prognosis after postoperative chemotherapy.
first_indexed 2024-03-09T17:52:18Z
format Article
id doaj.art-6c2773319a444e109c2dec4a6e01411e
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-09T17:52:18Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-6c2773319a444e109c2dec4a6e01411e2023-11-24T10:39:17ZengMDPI AGCancers2072-66942022-11-011423582510.3390/cancers14235825Hepatoblastoma Cancer Stem Cells Express PD-L1, Reveal Plasticity and Can Emerge upon ChemotherapyMieun Lee-Theilen0Delaine D. Fadini1Julia R. Hadhoud2Fleur van Dongen3Gabriela Kroll4Udo Rolle5Henning C. Fiegel6Department of Pediatric Surgery and Pediatric Urology, University Hospital, Goethe University Frankfurt, 60590 Frankfurt, GermanyDepartment of Pediatric Surgery and Pediatric Urology, University Hospital, Goethe University Frankfurt, 60590 Frankfurt, GermanyDepartment of Pediatric Surgery and Pediatric Urology, University Hospital, Goethe University Frankfurt, 60590 Frankfurt, GermanyDepartment of Pediatric Surgery and Pediatric Urology, University Hospital, Goethe University Frankfurt, 60590 Frankfurt, GermanyDepartment of Pediatric Surgery and Pediatric Urology, University Hospital, Goethe University Frankfurt, 60590 Frankfurt, GermanyDepartment of Pediatric Surgery and Pediatric Urology, University Hospital, Goethe University Frankfurt, 60590 Frankfurt, GermanyDepartment of Pediatric Surgery and Pediatric Urology, University Hospital, Goethe University Frankfurt, 60590 Frankfurt, GermanyThe biology of cancer stem cells (CSCs) of pediatric cancers, such as hepatoblastoma, is sparsely explored. This is mainly due to the very immature nature of these tumors, which complicates the distinction of CSCs from the other tumor cells. Previously, we identified a CSC population in hepatoblastoma cell lines expressing the CSC markers CD34 and CD90, cell surface Vimentin (csVimentin) and binding of OV-6. In this study, we detected the co-expression of the immune escape factor PD-L1 in the CSC population, whereas the other tumor cells remained negative. FACS data revealed that non-CSCs give rise to CSCs, reflecting plasticity of CSCs and non-CSCs in hepatoblastoma as seen in other tumors. When we treated cells with cisplatin and decitabine, a new CD34<sup>+/low</sup>OV-6<sup>low</sup>CD90<sup>+</sup> population emerged that lacked csVimentin and PD-L1 expression. Expression analyses showed that this new CSC subset shared similar pluripotency and EMT features with the already-known CSCs. FACS results further revealed that this subset is also generated from non-CSCs. In conclusion, we showed that hepatoblastoma CSCs express PD-L1 and that the biology of hepatoblastoma CSCs is of a plastic nature. Chemotherapeutic treatment leads to another CSC subset, which is highly chemoresistant and could be responsible for a poor prognosis after postoperative chemotherapy.https://www.mdpi.com/2072-6694/14/23/5825solid pediatric cancerhepatoblastomacancer stem cellsCD34CD90csVimentin
spellingShingle Mieun Lee-Theilen
Delaine D. Fadini
Julia R. Hadhoud
Fleur van Dongen
Gabriela Kroll
Udo Rolle
Henning C. Fiegel
Hepatoblastoma Cancer Stem Cells Express PD-L1, Reveal Plasticity and Can Emerge upon Chemotherapy
Cancers
solid pediatric cancer
hepatoblastoma
cancer stem cells
CD34
CD90
csVimentin
title Hepatoblastoma Cancer Stem Cells Express PD-L1, Reveal Plasticity and Can Emerge upon Chemotherapy
title_full Hepatoblastoma Cancer Stem Cells Express PD-L1, Reveal Plasticity and Can Emerge upon Chemotherapy
title_fullStr Hepatoblastoma Cancer Stem Cells Express PD-L1, Reveal Plasticity and Can Emerge upon Chemotherapy
title_full_unstemmed Hepatoblastoma Cancer Stem Cells Express PD-L1, Reveal Plasticity and Can Emerge upon Chemotherapy
title_short Hepatoblastoma Cancer Stem Cells Express PD-L1, Reveal Plasticity and Can Emerge upon Chemotherapy
title_sort hepatoblastoma cancer stem cells express pd l1 reveal plasticity and can emerge upon chemotherapy
topic solid pediatric cancer
hepatoblastoma
cancer stem cells
CD34
CD90
csVimentin
url https://www.mdpi.com/2072-6694/14/23/5825
work_keys_str_mv AT mieunleetheilen hepatoblastomacancerstemcellsexpresspdl1revealplasticityandcanemergeuponchemotherapy
AT delainedfadini hepatoblastomacancerstemcellsexpresspdl1revealplasticityandcanemergeuponchemotherapy
AT juliarhadhoud hepatoblastomacancerstemcellsexpresspdl1revealplasticityandcanemergeuponchemotherapy
AT fleurvandongen hepatoblastomacancerstemcellsexpresspdl1revealplasticityandcanemergeuponchemotherapy
AT gabrielakroll hepatoblastomacancerstemcellsexpresspdl1revealplasticityandcanemergeuponchemotherapy
AT udorolle hepatoblastomacancerstemcellsexpresspdl1revealplasticityandcanemergeuponchemotherapy
AT henningcfiegel hepatoblastomacancerstemcellsexpresspdl1revealplasticityandcanemergeuponchemotherapy